This is a Validated Antibody Database (VAD) review about rat GKLF, based on 5 published articles (read how Labome selects the articles), using GKLF antibody in all methods. It is aimed to help Labome visitors find the most suited GKLF antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
GKLF synonym: GKLF; Krueppel-like factor 4; Kruppel-like factor 4 (gut)
Santa Cruz Biotechnology
| mouse monoclonal (B-8) |
| Santa Cruz Biotechnology GKLF antibody (Santa Cruz, sc-393462) was used in immunocytochemistry on mouse samples (fig s1g). Cell Rep (2018) ncbi |
| mouse monoclonal (B-8) |
| In order to determine the necessity for differentiation-dependent viral life cycle by post-transciptional regulation of KLF4 by high-risk human papillomaviruses, Santa Cruz Biotechnology GKLF antibody (Santa Cruz Biotechnology, SC-393462) was used in immunoprecipitation on human samples (fig 5). PLoS Pathog (2016) ncbi |
| mouse monoclonal (F-8) |
| Santa Cruz Biotechnology GKLF antibody (Santa Cruz, sc-166238) was used in western blot on mouse samples (fig 3d,4a). J Cell Biochem (2015) ncbi |
| mouse monoclonal (F-8) |
| Santa Cruz Biotechnology GKLF antibody (Santa Cruz Technology, sc-166238) was used in western blot on rat samples at 1:500. Age (Dordr) (2014) ncbi |
Proteintech Group
| rabbit polyclonal |
| In order to study lncBRM and YAP1 signaling in liver cancer stem cells and hepatocellular carcinoma, Proteintech Group GKLF antibody (Proteintech, 11880-1-AP) was used in chromatin immunoprecipitation on human samples at 1:500 (fig 5d), in immunoprecipitation on human samples at 1:500 (fig 5a) and in western blot on human samples at 1:500 (fig 5a). Nat Commun (2016) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments
